Once again the hopes have been raised on the possible rethinking by the
government on lifting the moratorium issued on Bt Brinjal since Feb 9,
2010.
This is after the six National Science Academies (NSA) in India
submitted the report titled “The Role of GM Crops” to the Union
Minister of Environment and Forests (MoEF), Government of India.
In order to have the opinion of the distinguished scientists and
experts on the genetically modified crops, the MoEF had earlier asked
the NSAs to examine all aspects of safety and utility of GM crops to
Indian environment and agriculture.
The Agricultural Group (AG) of the Association of Biotechnology Led
Enterprises (ABLE) has also welcomed the report resubmitted by the six
NSAs. The ABLE – AG added that this report is based on complete
scientific assessment of the safety and utility of GM crops to Indian
agriculture.
Dr Shanthu Shantharam, executive director of ABLE-AG, said, “The
contents of academies report were based on scientific facts and this
latest report is in line with many other scientific reports and
opinions published by other leading scientific establishments of the
world.
When scientific reasoning prevails, and when politics and ideology are
kept out of science and technology issues, everyone wins.”
Govt to monitor pharma takeovers
Following recent takeovers of Indian pharmaceutical companies by
multinational companies (MNCs), there seems to be a possibility in a
rising number of similar takeovers. Considering the fact that these
events could have a direct impact on the Indian healthcare scenario as
well as on pricing and availability of medicines in India, the
government has felt an immediate need for an appropriate assessment, in
order to find out whether it will actually affect the patients in
India.
While revealing plans by the government in this regard, the Minister of
State for Chemicals and Fertilizers, Mr Srikant Kumar Jena said, “The
Department of Pharmaceuticals has requested the Department of Commerce
to conduct a study on the recent takeovers of Indian companies by MNCs.
Thereafter, the recommendation could be placed before the Economic
Advisory Council to the Prime Minister and/or competent authority.”
Pharma gets a funding boost
![](/IMG/930/45930/shutterstock38446015.jpg)
The Science and
Engineering Research Council (SERC) under the Department of Science and
Technology (DST), Government of India, has emerged as a national model
for a transparent and rigorous peer review mechanism. International
science and technology cooperation for joint funding through bottom-up
models is based on SERC peer view mechanism which demonstrates cultural
similarities with many developed countries in Europe.
SERC is planning to make efforts to come up with more product patents
and leverage the Indian pharma industry to take newer molecules for
clinical trial phases. The council also plans to study the diseases
prevalent among the captive as well as in restricted geographical area
of endangered animals and birds.
According to the Ministry of Science and Technology, under the SERC
mechanism, a total of 530 new projects costing about $35.58 mn (
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
160.3 crore) were sanctioned under broad areas
of science and engineering in 2009-10. In addition, funds were
sanctioned for about 1,250 ongoing projects. A total of 24 R&D
projects including collaborative and loan projects have been initiated
during the same year.
The DST is also putting efforts to financially support industries as
well as publicly funded institutions by providing projects for
development of drugs for diseases pertinent to our country and certain
lifestyle diseases like leprosy, malaria, tuberculosis, Japanese
encephalitis, syphilis, leishmaniasis, filariasis, HIV/AIDS, tetanus,
measles, drug resistant enteric Fever, hepatitis B, skin disorders such
as leucoderma and psoriasis, gastrointestinal disorders such as
diarrhoea and cholera besides infections leading to trypansomiasis and
ascariasis.
The Ministry of Science and Technology with a mandate to strengthen
R&D in India during the 11th Five Year Plan period has embarked
upon multi-pronged approach to further strengthen its service to the
science and technology sector.